Healthpeak Properties, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Scott Brinker
- Full Time Employees
- 411
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Address
- 4600 South Syracuse Street Denver CO United States of America 80237
- IPO Date
- May 23, 1985
- CIK
- 0000765880
- Website
- healthpeak.com
- Similar Companies
- Business
- Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated S&P 500 real estate investment trust that owns, operates, develops, and manages high-quality healthcare real estate focused on healthcare discovery and delivery; its core portfolio consists of outpatient medical buildings, life science laboratory facilities, and continuing care retirement communities (CCRCs), including prominent properties such as Torrey Pines Science Park and The Cove at Oyster Point in its lab segment, Medical City Dallas Hospital Campus in outpatient medical, and Freedom Plaza Sun City Center in CCRCs; the company also provides loans receivable and preferred equity investments secured by healthcare properties. Founded in 1985 and headquartered in Denver, Colorado, with additional offices in Irvine, Nashville, and San Francisco, Healthpeak conducts its operations across the United States through its umbrella partnership REIT structure, Healthpeak OP, LLC, targeting biopharma companies, health systems, physicians, and senior living operators in high-growth markets. Recent developments include the March 2024 merger with Physicians Realty Trust, which expanded its portfolio to nearly 50 million square feet and surpassed $65 million in annual synergies; a April 2025 long-term partnership with Hines for multifamily residential development at Cambridge Point in Massachusetts; two new $148 million outpatient medical development agreements with Northside Hospital in Atlanta submarkets during Q2 2025, with 78% pre-leased space; origination of $166 million in loans and investments in Q1 2025, including a $41 million outpatient loan in Frisco, Texas; promotion of leadership roles such as Denis Sullivan as Managing Director of Lab Investments and Mike Dorris as Head of West Coast Development in 2025; and a $500 million 5.375% senior notes issuance in February 2025 alongside ongoing share repurchases totaling over $94 million through April 2025.
5 Monthly Dividend Stocks Paying Up To 18.2%
Healthpeak & Brookfield Form Outpatient Medical Joint Venture
Healthpeak Properties and Brookfield Form a $2.1 Billion Strategic Joint Venture
3 Healthcare REITs to Buy as America Ages in July
Top 10 Dividend Stocks to Buy in 2026
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2026
3 REITs to Buy for Passive Income in July
Healthpeak Properties Gains 28% in 3 Months: Will the Trend Last?
5 High-Yielding S&P 500 Stocks Trading at Double-Digit Discounts Are Incredible Strong Buys Now
Healthpeak Properties: This 6% Yielding REIT Has More Room To Run
Healthpeak Properties Publishes Its 15th Annual Corporate Impact Report
Healthpeak Properties Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast
Alexandria Or Healthpeak? Your Risk Tolerance May Determine The Winner
Healthpeak (DOC) Down 2.2% Since Last Earnings Report: Can It Rebound?
EU clears Arla's DMK, DOC buyout, citing no competition concerns
Healthpeak Properties Gains 22.7% Year to Date: Will the Trend Last?
This Healthcare REIT Stands Out With 6.3% Yield
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity
Here Are Monday’s Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy’s, and More